Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using 18F-FDG PET

Journal of Nuclear Medicine

Volumn 52, Issue 11, 2011, Pages 1770-1777

  Cottone, Lucia ^a,b   Valtorta, Silvia ^a,c,d,e   Capobianco, Annalisa ^a   Belloli, Sara ^a,c,e   Rovere Querini, Patrizia ^a   Fazio, Ferruccio ^a,e   Manfredi, Angelo A ^a,b   Moresco, Rosa Maria ^a,c,e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

18F FDG PET; Clodronate; Inflammation; Macrophages; Peritoneal carcinomatosis

Indexed keywords

CLODRONIC ACID; FLUORODEOXYGLUCOSE F 18; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MACROPHAGE FUNCTION; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BIOLOGICAL TRANSPORT; DIFFUSION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; MACROPHAGES; MICE; MICE, INBRED BALB C; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY;

EID: 80455132113     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.089177     Document Type: Article

References (40)

1. Kunisaki C, Akiyama H, Nomura M, et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol. 2006;13:659-667.
2. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808-816. (Pubitemid 39425773)
3. Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol. 2003;21:233-248. (Pubitemid 37521721)
4. Margolis DJ, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. Molecular imaging techniques in body imaging. Radiology. 2007;245:333-356. (Pubitemid 47612513)
5. 18F-FDG PET/CT evaluation of patients with ovarian carcinoma. Nucl Med Commun. 2008;29:1046-1051.
6. Kim TJ, Ravoori M, Landen CN, et al. Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res. 2007;67:9337-9345. (Pubitemid 47535923)
7. 186Re-liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis. J Drug Target. 2008;16:626-637.
8. Nishiyama Y, Yamamoto Y, Kanenishi K, et al. Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET. Eur J Nucl Med Mol Imaging. 2008;35:287-295.
9. Mantovani A, Sica A, Allavena P, Garlanda C, Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol. 2009;70:325-330.
10. Bacci M, Capobianco A, Monno A, et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol. 2009;175:547-556.
11. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int. 2009;59:300-305.
12. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71-78. (Pubitemid 38082155)
13. Nanni P, de Giovanni C, Lollini PL, Nicoletti G, Prodi G. TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin Exp Metastasis. 1983;1:373-380. (Pubitemid 14221672)
14. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93.
15. Motta A, Damiani C, Del Guerra A, Di Domenico G, Zavattini G. Use of a fast EM algorithm for 3D image reconstruction with the YAP-PET tomograph. Comput Med Imaging Graph. 2002;26:293-302. (Pubitemid 36151584)
16. ImageJ. Available at: http://rsbweb.nih.gov/ij/. Accessed September 29, 2011.
17. Fong MY, Kakar SS. Ovarian cancer mouse models: a summary of current models and their limitations. J Ovarian Res. 2009;2:12.
18. Brown RS, Fisher SJ, Wahl RL. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med. 1993;34:75-82. (Pubitemid 23014230)
19. Hüsemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13:58-68. (Pubitemid 350309740)
20. Engelstaedter V, Mylonas I. Lower genital tract metastases at time of first diagnosis of mammary invasive lobular carcinoma. Arch Gynecol Obstet. 2011;283 (suppl 1:93-95.
21. van Rooijen N. Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages. J Drug Target. 2008;16:529-534.
22. Mönkkönen J, Heath TD. The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron. Calcif Tissue Int. 1993;53:139-146. (Pubitemid 23215390)
23. van Rooijen N. Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis. Calcif Tissue Int. 1993;52:407-410.
24. Buiting AM, Zhou F, Bakker JA, van Rooijen N, Huang L. Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide'approach. J Immunol Methods. 1996;192:55-62. (Pubitemid 26199198)
25. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23-35. (Pubitemid 37328697)
26. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958-969.
27. Coffelt SB, Hughes R, Lewis CE. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta. 2009;1796:11-18.
28. Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231-237.
29. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202:654-662. (Pubitemid 40175840)
30. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029-1033.
31. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11-20.
32. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
33. 18F]fluoro-D-glucose and positron emission tomography. Gastroenterology. 2008;135:744-755.
34. Rosenbaum SJ, Lind T, Antoch G, Bockisch A. false-positive FDG PET uptake: the role of PET/CT. Eur Radiol. 2006;16:1054-1065.
35. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301-1306.
36. Brepoels L, Stroobants S, Vandenberghe P, et al. Effect of corticosteroids on F-FDG uptake in tumor lesions after chemotherapy. J Nucl Med. 2007;48: 390-397.
37. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412-1417.
38. Nair-Gill E, Wiltzius SM, Wei XX, et al. PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice. J Clin Invest. 2010;120:2005-2015.
39. DeNardo DG. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discovery. 2011;1:52-65.
40. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39-51.